None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of type-2 diabetes mellitus, age 30-60 years taking Metformin for more than 3 months with uncontrolled hyperglycaemia i.e.HbA1C between 7% to 9% and Body Mass Index (BMI) between 25-29.9 kg/m2. 2. Patients who are able and willing to follow anti-diabetic therapy under a stable life style and diabetic diet. 3.Patients who are willing and able to understand and follow the protocol and provide informed consent.
Exclusion criteria
Exclusion criteria: 1.History of treatment with any insulin 2.Diabetes mellitus with complications 3.Pregnant or Lactating women 4.Women of childbearing potential who do not take adequate contraceptive protection. 5.History of hypersensitivity to the Metformin or to drug with similar chemical structure. 6.History of any severe systemic disease. 7.Patients with uncontrolled hypertension. 8.History of drug or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean HbA1C 6.5%Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To achieve a good glycemic control (FPG-80-120 mg/dl; PPG-80-140 mg/dl)Timepoint: 4,8,12 week | — |
Countries
India
Contacts
Dept. of Moalajat SUMER